cisplatin + vinblastine + SHAO

This is a combination regimen consisting of **cisplatin** (a platinum-based chemotherapeutic agent), **vinblastine** (a vinca alkaloid antineoplastic), and **SHAO**. Cisplatin causes DNA crosslinking and apoptosis in rapidly dividing cells, while vinblastine inhibits microtubule formation, leading to mitotic arrest. The mechanism, identity, or function of "SHAO" is unknown based on provided data and standard databases. Cisplatin and vinblastine are used together in oncological settings, primarily for cancers such as testicular cancer, non-small-cell lung cancer, and urothelial carcinoma, but the specific combination with "SHAO" is not described in the medical literature[2][3].